Montelukast and Churg-Strauss syndrome.
B J
BJ
Lipworth
A M
AM
Wilson
D000085:Acetates / Q000009:adverse effects*; D000280:Administration, Inhalation; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D015267:Churg-Strauss Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D003521:Cyclopropanes; D004305:Dose-Response Relationship, Drug; D004802:Eosinophilia / Q000139:chemically induced; D000068298:Fluticasone; D006801:Humans; D009330:Nebulizers and Vaporizers; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011804:Quinolines / Q000009:adverse effects*; D013440:Sulfides
D000085:Acetates; D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D003521:Cyclopropanes; D011804:Quinolines; D013440:Sulfides; D011239:Prednisolone; D000068298:Fluticasone; C093875:montelukast